The Universal Selection Source:
Plastics & Elastomers
Product News

Solvay’s New PEEK Used as Base Polymer in Osteoconductive Composite for Spinal Implants

Published on 2017-11-28. Author : SpecialChem

Solvay’s biocompatible Zeniva® ZA-500 PEEK was chosen by DiFusion Technologies for use in its ZFUZE osteoconductive PEEK composite for spinal implants
Solvay’s biocompatible Zeniva® ZA-500 PEEK was chosen by
DiFusion Technologies for use in its ZFUZE osteoconductive
PEEK composite for spinal implants
Solvay has announced that medical device-maker DiFusion Technologies chose Zeniva® ZA-500 polyetheretherketone (PEEK) as the base polymer for its ZFUZE osteoconductive PEEK composite for spinal implants. The new compound exhibited large areas of new bone formation on all bone implant surfaces in recent testing by DiFusion, who shared its results at the recent NASS 2017 event in Orlando.

Metal-replacing Biocompatible Polymer

PEEK is an attractive alternative to titanium for spinal implants because it shares similar modulus to bone, and its radio transparency allows for easy visualization in X-rays. The polymer is also inert, which means it does not interact with human tissue. While this quality supports biocompatibility, it means that PEEK does not naturally lend itself to bone growth. DiFusion solved this problem by compounding negatively charged zeolites into Solvay’s Zeniva® PEEK polymer.

Penicillin Moment

Derrick Johns, CEO of DiFusion Technologies, said:
“It was sort of a penicillin moment. We started out engineering anti-microbial polymers by first loading zeolite particles with silver before compounding them. But we discovered if we took the silver cations out of the zeolite, they imbued PEEK with a negative charge. Osteoblast cells are attracted to the negatively charged surface at a far higher rate than titanium, and yet we were able to preserve the polymer’s outstanding visualization, modulus and strength benefits.”

ZFUZE Composite Technology

Solvay was an early collaborator in the development of DiFusion’s patented ZFUZE composite, combining industry-leading materials expertise with technical and regulatory support for medical devices. Zeniva® ZA-500 PEEK was of particular interest to DiFusion due to the polymer’s higher flow, which facilitates both the compounding process and the extrusion of osteoconductive implants.

Jeff Hrivnak, global business manager for Healthcare at Solvay’s Specialty Polymers Business Unit, said:
“In addition to our materials expertise, Solvay’s open innovation business model was instrumental to the successful innovation of DiFusion’s ZFUZE osteoconductive composite. Our uniquely collaborative approach to customer projects differentiates us from other PEEK suppliers in this industry, and it allowed us to pool our respective capabilities and resources with DiFusion to solve this demanding challenge.”

FDA Approval

DiFusion’s ZFUZE composite technology is in the final stages of its 510K approval process with the U.S. Food and Drug Administration. It is expected to be commercially available in the U.S. early next year.

® Zeniva is a registered trademark of Solvay.

PS: If you liked this News, you might enjoy our Plastics & Elastomers Product Newsletter. All the Product News delivered once a week right to your inbox. Sign up here!

Source: Solvay
Fluoropolymers and chemistry that make a difference
The Chemicals Sales & Marketing Toolbox
Back to Top